Related Experiment Video
Updated: Aug 13, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Calcineurin nephrotoxicity
David Williams1, Lukas Haragsim
1Department of Medicine, University of Oklahoma, Oklahoma City, OK 73104, USA.
Abstract:
Calcineurin inhibitors, cyclosporine and tacrolimus, have improved allograft survival in solid organ transplantation. Indeed, they have reduced the incidence of acute rejection episodes of cadaveric allograft recipients. Although marked progression has been made in initial survival rates, long-term kidney graft survival has yet to show such encouraging results. Chronic allograft dysfunction is the major hindrance to long-term graft survival and many components contribute to this entity, both immunologic and nonimmunologic. Chronic calcineurin nephrotoxicity is a major factor in chronic allograft dysfunction. This review will highlight the current understanding and management of calcineurin nephrotoxicity in kidney transplantation.
Insights
Calcineurin inhibitors improve initial transplant survival but chronic nephrotoxicity hinders long-term kidney graft survival. This review covers calcineurin inhibitor nephrotoxicity in kidney transplantation.
Area of Science:
- Nephrology
- Immunology
- Transplantation
Background:
- Calcineurin inhibitors (cyclosporine, tacrolimus) enhance solid organ transplant survival.
- These drugs reduce acute rejection in cadaveric allograft recipients.
- Long-term kidney graft survival remains suboptimal despite improved initial outcomes.
Purpose of the Study:
- To review the current understanding of calcineurin inhibitor nephrotoxicity.
- To discuss the management strategies for calcineurin inhibitor nephrotoxicity in kidney transplant recipients.
Main Methods:
- Literature review of calcineurin inhibitor nephrotoxicity.
- Analysis of factors contributing to chronic allograft dysfunction.
- Synthesis of current management approaches.
Main Results:
- Chronic calcineurin inhibitor nephrotoxicity is a significant cause of chronic allograft dysfunction.
- Both immunologic and nonimmunologic factors contribute to chronic allograft dysfunction.
- Effective management strategies are crucial for improving long-term graft survival.
Conclusions:
- While calcineurin inhibitors are vital for preventing acute rejection, their long-term nephrotoxic effects pose a challenge.
- Addressing chronic calcineurin inhibitor nephrotoxicity is essential for enhancing long-term kidney allograft survival.
- Further research and optimized management protocols are needed to mitigate calcineurin inhibitor-induced kidney damage.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrons
Acute Kidney Injury II: Pathophysiology
Kidney Transplant II: Surgical Procedure
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi I: Introduction
